Synthetically functionalized retroviruses produced from the bioorthogonally engineered cell surface

Bioconjugate Chemistry

Volumn 22, Issue 2, 2011, Pages 151-155

  Wong, Shirley ^a   Kwon, Young Jik ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of California at Irvine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCENT DYE; MAGNETIC NANOPARTICLE; SIALIC ACID;

ARTICLE; BIOENGINEERING; CELL SURFACE; CONJUGATION; NONHUMAN; OXIDATION; RETROVIRUS; VIRUS ENVELOPE;

EID: 79951696910     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc100516h     Document Type: Article

References (26)

1. Cavazzana-Calvo, M., Hacein-Bey, S., de Saint Basile, G., Gross, F., Yvon, E., Nusbaum, P., Selz, F., Hue, C., Certain, S., Casanova, J. L., Bousso, P., Le Deist, F., and Fischer, A. (2000) Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease Science 288, 669-672
2. Sterman, D. H., Treat, J., Litzky, L. A., Amin, K. M., Coonrod, L., Molnar-Kimber, K., Recio, A., Knox, L., Wilson, J. M., Albelda, S. M., and Kaiser, L. R. (1998) Adenovirus-mediated herpes simplex virus thymidine kinase gene delivery in patients with localized malignancy: Results of a phase 1 clinical trial in malignant mesothelioma Hum. Gene Ther. 7, 1083-1092
3. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., and Yamanaka, S. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors Cell 131, 1-12
4. Edelstein, M. L., Abedi, M. R., and Wixon, J. (2007) Gene therapy clinical trials worldwide to 2007 - an update J Gene Med. 9, 833-842
5. Kohn, D. B., Bauer, G., Rice, R., Rothschild, J. C., Carbonaro, D. A., Valdez, P., Hao, Q. H., Zhou, C., Bahner, I., Kearns, K., Brody, K., Fox, S., Haden, E., Wilson, K., Salata, C., Dolan, C., Wetter, C., Aguilar-Cordova, E., and Church, J. (1999) A clinical trial of retroviral-mediated transfer of a rev-responsive element decoy gene into CD34+ cells from the bone marrow of human immunodeficiency virus-1-infected children Blood 94, 368-371
6. Rodrigues, T., Carvalho, A., Roldao, A., Carrondo, M. J. T., Alves, P. M., and Cruz, P. E. (2006) Screening anion-exchange chromatographic matrices for isolation of onco-retroviral vectors J. Chromatogr., B 837, 59-68
7. Baekelandt, V., Eggermont, K., Michiels, M., Nuttin, B., and Debyser, A. (2003) Optimized lentiviral vector production and purification procedures prevents immune response after transduction of mouse brain Gene Ther. 10, 1933-1940
8. Yang, Y. and Wilson, J. M. (1995) Clearance of adenovirus-infected hepatocytes by MHC class I-restricted CD4+ CTLs in vivo J. Immunol. 155, 2564-2570
9. Recchia, A., Parks, R. J., Lamartina, S., Toniatti, C., Pieroni, L., Palombo, F., Ciliberto, G., Graham, F. L., Cortese, R., La Monica, N., and Colloca, S. (1999) Site-specific integration mediated by a hybrid adenovirus/adeno-associated virus vector Proc. Natl. Acad. Sci. U.S.A. 96, 2615-2620
10. Saha, K. and Wong, P. K. Y. (1994) A simple method for obtaining highly viable virus from culture supernatant J. Virol. Methods 46, 349-352
11. Lei, Y., Joo, K., Zarzar, J., Wong, C., and Wang, P. (2010) Targeting lentiviral vector to specific cell types through surface displayed single chain antibody and fusogenic molecule Virol. J. 7, 1-12
12. Tuschong, L., Soenen, S. L., Blaese, R. M., Candotti, F., and Muul, L. M. (2002) Immune response to fetal calf serum by two adenosine deaminase-deficient patients after T cell gene therapy Hum. Gene Ther. 13, 1605-1010
13. Burns, J. C., Friedmann, T., Driever, W., Burrascano, M., and Yee, J. K. (1993) Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells Proc. Natl. Acad. Sci. U.S.A. 90, 8033-8037
14. Morizono, K., Xie, Y., Helguera, G., Daniels, T. R., Lane, T. F., Penichet, M. L., and Chen, I. S. Y. (2009) A versatile targeting system with lentiviral vectors bearing the biotin-adaptor peptide J. Gene Med. 11, 655-663
15. Pariente, N., Mao, S. H., Morizono, K., and Chen, I. S. Y. (2008) Efficient targeted transduction of primary human endothelial cells with dual-targeted lentiviral vectors J. Gene Med. 10, 242-248
16. Steinmetz, N. F. (2010) Viral nanoparticles as platforms for next-generation therapeutics and imaging devices Nanomedicine 6, 1-10
17. O'Riordan, C. R., Lachapelle, A., Delgado, C., Parkes, V., Wadsworth, S. C., Smith, A. E., and Francis, G. E. (1999) PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivo Hum. Gene Ther. 10, 1349-1358
18. Zhong, Q., Koll, J. K., and Schwarzenberger, P. (2001) A novel, high transduction efficiency, potentially safety-improved, gene transfer system J. Biol. Chem. 276, 24601-24607
19. Boerger, A. L., Snitkovsky, S., and Young, J. A. T. (1999) Retroviral vectors preloaded with a viral receptor-ligand bridge protein are targeted to specific cell types Proc. Natl. Acad. Sci. U.S.A. 96, 9867-9872
20. Benedict, C. A., Tun, R. Y. M., Rubinstein, D. B., Guillaume, T., Cannon, P. M., and Anderson, W. F. (1999) Targeting retroviral vectors to CD34-expressing cells: binding to CD34 does not catalyze virus-cell fusion Hum. Gene Ther. 10, 545-557
21. Williams, S. L., Nesbeth, D., Darling, D. C., Farzaneh, F., and Slater, N. K. H. (2005) Affinity recovery of Moloney Murine Leukemia Virus J. Chromatogr., B 820, 111-119
22. Ory, D. S., Neugeboren, B. A., and Mulligan, R. C. (1996) A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes Proc. Natl. Acad. Sci. U.S.A. 93, 11400-11406
23. Zeng, Y., Ramya, T. N. C., Dirksen, A., Dawson, P. E., and Paulson, J. C. (2009) High-efficiency labeling of sialylated glycoproteins on living cells Nat. Methods 6, 207-209
24. Volz, B., Orberger, G., Porwoll, S., Hauri, H. P., and Tauber, R. (1995) Selective reentry of recycling cell surface glycoproteins to the biosynthetic pathway in human hepatocarcinoma HepG2 cells J. Cell Biol. 130, 537-551
25. Singh, R. and Kostarelos, K. (2009) Designer adenoviruses for nanomedicine and nanodiagnostics Cell 27, 220-229
26. Raty, J. K., Liimatainen, T., Wirth, T., Airenne, K. J., Ihalainen, T. O., Huhtala, T., Hamerlynck, E., Vihinen-Ranta, M., Narvanen, A., Yla-Herttuala, S., and Hakumaki, J. M. (2006) Magnetic resonance imaging of viral particle biodistribution in vivo Gene Ther. 13, 1440-1446